ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novartis phase II data for new inhaled combination treatment (QVM149) demonstrates significant improvements over current standard-of-care inhaled treatment
May 24, 2019Novartis announced today that new phase II data for IND/GLY/MF (QVM149), an investigational, once-daily, fixed dose combination asthma treatment containing indacaterol acetate ... -
Vertex wins European approval for new cystic fibrosis combination
December 17, 2018European regulators have approved Vertex’s new cystic fibrosis (CF) combination treatment Symkevi.The European Commission’s greenlight for Symkevi (tezacaftor/ivacaftor) will allow.....
Pharma Sources Insight January 2025
